Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Stem cell transplantation has emerged as a relatively popular treatment that can help to
regulate immunity, repair injury, and control inflammation. Several studies have used
autologous stem cells or adipose-derived stem cells to treat Crohn's disease and its
associated complications, and have achieved good efficacy. Thus far, the use of umbilical
cord mesenchymal stem cells (UC-MSCs) to treat Crohn's disease has rarely been reported. In
this study, UC-MSCs were used to treat patients with hormone-controlled Crohn's disease. We
observed the disease control conditions, corticosteroid dosage changes, and treatment-related
adverse reactions.